These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 3186649)

  • 1. [Effect of prostaglandin El (alprostadil) on pulmonary hypertension in patients with chronic obstructive respiratory tract diseases (COPD)].
    Gassner A; Sommer G; Fridrich L; Magometschnigg D; Priol A
    Prax Klin Pneumol; 1988 Jul; 42(7):521-4. PubMed ID: 3186649
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of prostaglandin E1 (PGE1) in pulmonary hypertension due to chronic obstructive pulmonary disease (COPD).
    Meissner E; Creutzig A; Fabel H
    Prog Clin Biol Res; 1989; 301():253-7. PubMed ID: 2798450
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of salbutamol on pulmonary circulation, ventilation and gas exchange in patients with chronic obstructive airways disease. Preliminary report.
    Koziorowski A; Zielinski J; Maszczyk Z; Pawlicka L; Klimkiewicz H
    Bull Physiopathol Respir (Nancy); 1972; 8(3):611-6. PubMed ID: 4405131
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hemodynamic and respiratory effects of phentolamine in pulmonary hypertension secondary to chronic obstructive syndrome].
    Domenighetti G; Leuenberger P; Perret C
    Schweiz Med Wochenschr; 1985 Jan; 115(3):99-103. PubMed ID: 3975579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Variable hemodynamic response to nifedipine in pulmonary hypertension secondary to chronic obstructive bronchopathy and pulmonary fibrosis].
    Domenighetti G
    Schweiz Med Wochenschr; 1985 Sep; 115(39):1345-7. PubMed ID: 4071009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose inhalation therapy with nitric oxide and oxygen--implications for long-term application in patients with COPD and pulmonary hypertension.
    Leitner C; Ziesche R; Zimpfer M; Block LH; Germann P
    Acta Anaesthesiol Scand Suppl; 1996; 109():96-7. PubMed ID: 8901962
    [No Abstract]   [Full Text] [Related]  

  • 7. [The role of renin-angiotensin system in pathogenesis of pulmonary hypertension in patients with chronic obstructive pulmonary disease].
    Frangulian RR
    Klin Med (Mosk); 2000; 78(10):18-20. PubMed ID: 11220892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hemodynamic effects of amrinone and comparison with dobutamine in patients with chronic respiratory insufficiency with pulmonary hypertension].
    Faitg R; Coulaud JM; Rezgui N; Brulot N; Clavier H; Besse B; Labrousse J; Lissac J
    Ann Cardiol Angeiol (Paris); 1989 Jun; 38(6):333-7. PubMed ID: 2757350
    [No Abstract]   [Full Text] [Related]  

  • 9. Nitroglycerin and isosorbide dinitrate in pulmonary hypertension of chronic obstructive pulmonary disease.
    Delaunois L; Jonard P; Kremer N; Dubois P; Lulling J
    Bull Eur Physiopathol Respir; 1984; 20(1):11-8. PubMed ID: 6423015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of a new calcium antagonist, felodipine, on pulmonary hypertension and gas exchange in chronic obstructive lung disease.
    Bratel T; Hedenstierna G; Nyquist O; Ripe E
    Eur J Respir Dis; 1985 Oct; 67(4):244-53. PubMed ID: 4076363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of pulmonary hypertension in patients with chronic obstructive pulmonary disease: position of vasodilators with special focus on urapidil.
    Adnot S; Samoyeau R; Weitzenblum E
    Blood Press Suppl; 1995; 3():47-57. PubMed ID: 8535542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effects of diltiazem on pulmonary hemodynamics and oxygenation in copd induced pulmonary hypertension].
    Fang B; Wang C; Dai H
    Zhonghua Yi Xue Za Zhi; 1998 Oct; 78(10):779-81. PubMed ID: 11038835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two-week nifedipine treatment for pulmonary hypertension complicating chronic obstructive lung disease.
    Saadjian A; Philip-Joet F; Guintoli A; Torresani J; Arnaud A
    Eur J Respir Dis; 1985 Nov; 67(5):346-50. PubMed ID: 4085586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sildenafil therapy in secondary pulmonary hypertension: Is there benefit in prolonged use?
    Chapman TH; Wilde M; Sheth A; Madden BP
    Vascul Pharmacol; 2009; 51(2-3):90-5. PubMed ID: 19386283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostaglandin E1 in the pretransplantation period in patients with pulmonary hypertension.
    Wasler A; Iberer F; Tscheliessnigg KH; Auer T; Petutschnigg B
    J Heart Lung Transplant; 1993; 12(5):884. PubMed ID: 8241236
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of nitroglycerin on various indicators of hemodynamics in patients with chronic obstructive bronchitis complicated by pulmonary hypertension].
    Aleksandrov AL; Matkovskii SK; Cherniakova TG
    Ter Arkh; 1985; 57(5):45-7. PubMed ID: 3927499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of inhalation of an atropine derivative (SCH 1000) on airway resistance to flow and on specific conductance in patients with chronic obstructive bronchopneumopathy].
    Anastasatu C; Duţu S
    Ftiziologia; 1974 May; 23(3):305-10. PubMed ID: 4842470
    [No Abstract]   [Full Text] [Related]  

  • 18. [Severe obstructive lung disease. The effect of the calcium antagonist isradipine on working capacity, pulmonary function, morbidity and survival].
    Petersen JR; Galløe AM; Graudal NA; Galløe M
    Ugeskr Laeger; 1993 Aug; 155(34):2612-5. PubMed ID: 8212369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of tetrandrine on pulmonary hypertension in patients with chronic obstructive pulmonary disease].
    Kang J
    Zhonghua Jie He He Hu Xi Za Zhi; 1993 Feb; 16(2):93-4, 124. PubMed ID: 8221961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of the administration of Ca++ antagonist on bronchial resistance in subjects with chronic obstructive bronchopneumopathy].
    Bonaduce D; Ferrara N; Postiglione M; Petretta M; Covelli A; Romano E; Rengo F
    Boll Soc Ital Cardiol; 1978; 23(9):1515-21. PubMed ID: 553625
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.